Brokerages Set LivaNova PLC (LIVN) Price Target at $58.00
LivaNova PLC (NASDAQ:LIVN) has been given an average recommendation of “Hold” by the six research firms that are currently covering the stock, Marketbeat reports. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and one has given a buy rating to the company. The average twelve-month price objective among analysts that have covered the stock in the last year is $58.00.
A number of research analysts recently issued reports on LIVN shares. Needham & Company LLC started coverage on shares of LivaNova PLC in a research note on Wednesday, August 23rd. They issued a “hold” rating on the stock. BidaskClub cut shares of LivaNova PLC from a “strong-buy” rating to a “buy” rating in a research note on Monday, July 24th. WBB Securities cut shares of LivaNova PLC from a “hold” rating to a “sell” rating and set a $50.00 price objective on the stock. in a research note on Tuesday, August 15th. Finally, Berenberg Bank reissued a “buy” rating and issued a $70.00 price objective on shares of LivaNova PLC in a research note on Friday, August 11th.
COPYRIGHT VIOLATION WARNING: “Brokerages Set LivaNova PLC (LIVN) Price Target at $58.00” was published by Watch List News and is the property of of Watch List News. If you are reading this piece on another site, it was illegally stolen and republished in violation of U.S. and international trademark & copyright laws. The legal version of this piece can be viewed at https://www.watchlistnews.com/brokerages-set-livanova-plc-livn-price-target-at-58-00/1528414.html.
LivaNova PLC (NASDAQ:LIVN) traded down 0.32% on Wednesday, reaching $61.49. The company’s stock had a trading volume of 119,476 shares. The stock’s 50 day moving average is $61.60 and its 200-day moving average is $56.05. LivaNova PLC has a 52 week low of $40.83 and a 52 week high of $64.95. The firm has a market capitalization of $3.00 billion, a PE ratio of 109.80 and a beta of 0.62.
LivaNova PLC (NASDAQ:LIVN) last announced its quarterly earnings data on Wednesday, August 9th. The company reported $1.01 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.82 by $0.19. The business had revenue of $321.40 million for the quarter, compared to analysts’ expectations of $315.75 million. LivaNova PLC had a net margin of 2.26% and a return on equity of 9.08%. LivaNova PLC’s revenue for the quarter was up .1% compared to the same quarter last year. Analysts predict that LivaNova PLC will post $3.22 EPS for the current year.
In related news, Director Daniel Jeffrey Moore sold 1,000 shares of LivaNova PLC stock in a transaction that occurred on Monday, July 17th. The shares were sold at an average price of $61.55, for a total value of $61,550.00. Following the transaction, the director now directly owns 56,437 shares of the company’s stock, valued at $3,473,697.35. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders sold 3,000 shares of company stock worth $183,110 over the last three months. 0.28% of the stock is currently owned by insiders.
Several hedge funds have recently bought and sold shares of the company. Icon Advisers Inc. Co. bought a new stake in LivaNova PLC during the first quarter worth $333,000. Swiss National Bank boosted its stake in LivaNova PLC by 1.8% in the first quarter. Swiss National Bank now owns 72,719 shares of the company’s stock worth $3,564,000 after buying an additional 1,300 shares during the last quarter. Comerica Bank boosted its stake in LivaNova PLC by 3.8% in the first quarter. Comerica Bank now owns 31,907 shares of the company’s stock worth $1,672,000 after buying an additional 1,182 shares during the last quarter. Cambiar Investors LLC boosted its stake in LivaNova PLC by 16.9% in the first quarter. Cambiar Investors LLC now owns 7,841 shares of the company’s stock worth $384,000 after buying an additional 1,136 shares during the last quarter. Finally, Bank of New York Mellon Corp boosted its stake in LivaNova PLC by 5.1% in the first quarter. Bank of New York Mellon Corp now owns 374,488 shares of the company’s stock worth $18,353,000 after buying an additional 18,042 shares during the last quarter. 82.36% of the stock is currently owned by hedge funds and other institutional investors.
LivaNova PLC Company Profile
LivaNova PLC is a medical device company focused on the development and delivery of therapeutic solutions. The Company’s segments include Cardiac Surgery, Cardiac Rhythm Management, Neuromodulation and Other. The Cardiac Surgery segment is engaged in the development, production and sale of cardiovascular surgery products.
Receive News & Ratings for LivaNova PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LivaNova PLC and related companies with Analyst Ratings Network's FREE daily email newsletter.